2192 — Medlive Technology Co Income Statement

0.000.00%

Last trade - 00:00

Consumer CyclicalsHighly SpeculativeMid CapSuper Stock

Annual income statement for Medlive Technology Co, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	PROSPECTUS	PROSPECTUS	ARS	ARS	PRESS
Standards:	IFRS	IFRS	IFRS	IFRS	—
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	122	214	284	314	412
Cost of Revenue
Gross Profit	77.2	156	201	213	251
Selling / General / Administrative Expenses
Research And Development
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	84.3	108	214	178	159
Operating Profit	37.3	105	70.5	136	253
Total Net Non Operating Interest Income / Expense
Net Income Before Taxes	37	105	69.9	135	253
Provision for Income Taxes
Net Income After Taxes	31.3	85.2	45.2	126	252
Minority Interest
Net Income Before Extraordinary Items
Net Income	31.3	85.2	40.6	117	242
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	31.3	85.2	40.6	117	242
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	0.045	0.122	0.093	0.158	0.33
Dividends per Share